SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001493152-22-011241
Filing Date
2022-04-26
Accepted
2022-04-26 17:01:22
Documents
78

Document Format Files

Seq Description Document Type Size
1 formposam.htm   iXBRL POS AM 3734976
2 ex5-1.htm EX-5.1 10646
3 ex23-1.htm EX-23.1 6474
4 ex107.htm EX-FILING FEES 10859
5 ex5-1_001.jpg GRAPHIC 4365
  Complete submission text file 0001493152-22-011241.txt   12966536

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20211231.xsd EX-101.SCH 74753
7 XBRL CALCULATION FILE otlc-20211231_cal.xml EX-101.CAL 63897
8 XBRL DEFINITION FILE otlc-20211231_def.xml EX-101.DEF 439234
9 XBRL LABEL FILE otlc-20211231_lab.xml EX-101.LAB 583384
10 XBRL PRESENTATION FILE otlc-20211231_pre.xml EX-101.PRE 528749
72 EXTRACTED XBRL INSTANCE DOCUMENT formposam_htm.xml XML 2061532
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-256448 | Film No.: 22855190
SIC: 2834 Pharmaceutical Preparations